A Global Aesthetic Company
We have built a portfolio of differentiated, complementary aesthetics technologies, targeting unmet clinical needs for effective, high quality, longer duration, natural-looking and minimally-invasive treatments.
Sinclair Pharma Announces Exclusive Worldwide Licence Agreement for Ground-breaking Range of Injectable Hyaluronic Acid Products
Sinclair Pharma Announces transfer of Distribution Rights for Sculptra® in Western Europe to Galderma. Sale provides Sinclair Pharma with resources and opportunity to expand aesthetic product portfolio.
Sinclair Pharma Announces Acquisition of Cocoon Medical and Expansion into Energy-Based Devices (EBD)
Sinclair Pharma Continues Global Expansion with the Introduction of Silhouette InstaLift® in Canada.